Cytokines associated with Inflammatory Bowel Disease

ISSN: 1875-631X (Online)
ISSN: 1573-3955 (Print)


Volume 10, 2 Issues, 2014


Download PDF Flyer




Current Immunology Reviews

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Cecil Czerkinsky
Institut de Pharmacologie Moleculaire et Cellulaire
UMR 7275 CNRS-INSERM-UNISA
660 Route des Lucioles
Valbonne, 06560
France


View Full Editorial Board

Subscribe Purchase Articles Order Reprints


Cytokines associated with Inflammatory Bowel Disease

Author(s): Gabriela Fonseca-Camarillo and Jesús K. Yamamoto-Furusho

Affiliation: Head of IBD Clinic, Department of Gastroenterology Instituto Nacional de Ciencias Médicas y Nutrición Vasco de Quiroga #15. Col. Sección XVI, Tlalpan, CP 14000 México.

Abstract

The Inflammatory Bowel Disease (IBD) comprises two forms Ulcerative Colitis (UC) and Crohn's Disease (CD). The intestinal inflammation in IBD is controlled by a complex interplay of innate and adaptive immune mechanisms. Evidence indicates that a dysregulation of these mechanisms in the mucosal immunity of the gut in IBD patients causes an overproduction of cytokines leading to an uncontrolled intestinal inflammation. The discovery of novel cytokines in the IBD is important in order to understand the mechanisms that are involved in the gut mucosal immunity, as well as the design of new therapeutic targets focused on the production of specific cytokine inhibitors.


Purchase Online Order Reprints Order Eprints Rights and Permissions

  
  



Article Details

Volume: 9
First Page: 1
Page Count: 1
DOI: 10.2174/157339551130900009
Advertisement

Related Journals




Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science